Eli Lilly Stock a Buy After FDA Signs Off on New Weight-Loss Drug? Hosted by MarketBeat StaffNovember 28, 2023 ShareLink copied to clipboard. Play video for Eli Lilly Stock a Buy After FDA Signs Off on New Weight-Loss Drug?DetailsGuestsIn this video, we dive into the evolving pharmaceutical landscape with Dylan Jovine from Behind the Markets. We unpack the explosive growth expected in the weight loss drug industry, projected to hit a whopping $150-200 billion by 2030. There are major players strategically positioning themselves in this market, and we'll uncover the intense competition between giants like Novo Nordisk and Eli Lilly, fighting for dominance with their groundbreaking weight loss drugs. Plus, discover the potential impact on stock values and the healthcare industry as a whole. We'll also discuss the critical phase transitions in FDA drug approval, spotting opportunities, and why investing in biotech has Dylan so bullish on its future.Read Ozempic vs. Mounjaro:: Battle of the bulgeStocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioLLYEli Lilly and Company4.6381 of 5 stars4.64 / 5 stars$805.12-2.0%0.65%118.57NVONovo Nordisk A/S3.751 of 5 stars3.75 / 5 stars$126.72-0.9%1.05%43.70 Compare These Stocks Add These Stocks to My Watchlist Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeat625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored8 Retail Stocks to Own For the Long HaulAfter the 2020 e-commerce boom, everyone thought we had taken a 10-year leap in online shopping. Amazon was op...MarketBeat“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | Sponsored20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves a company that pays strong dividends. Who doesn't like receiving a check every quarter f...MarketBeatNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsored7 Dividend Dynamos with a Yield of More Than 7%Despite signs of a slowing economy, investors continue to climb the wall of worry. And let's face it, many of ...MarketBeat 3 Strong Buy Stocks for a Summer SurgeIn this video, we break down the factors driving the market's impressive performance and why the S&P could rise another 15% by year's end.Recent Videos Featured Articles and OffersWhy This AI Stock is Rising Despite Tech Sell-OffJuly 20, 2024View Why This AI Stock is Rising Despite Tech Sell-OffNext opportunity for crypto millionsFrom Crypto 101 Media(Ad)View Next opportunity for crypto millionsInnovative Robotics Stock Rockets 187% on NVIDIA InvestmentJuly 22, 2024View Innovative Robotics Stock Rockets 187% on NVIDIA InvestmentTesla Skids Into a Buying Opportunity But Don’t Buy it YetJuly 24, 2024View Tesla Skids Into a Buying Opportunity But Don’t Buy it YetTop 4 High-Yield Dividend Stocks to Add to Your PortfolioJuly 22, 2024View Top 4 High-Yield Dividend Stocks to Add to Your PortfolioIs Apple Plotting to Kill Its iPhone?From Banyan Hill Publishing(Ad)View Is Apple Plotting to Kill Its iPhone? Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by MarketBeat StaffNovember 28, 2023 ShareLink copied to clipboard. Play video for Eli Lilly Stock a Buy After FDA Signs Off on New Weight-Loss Drug?DetailsGuestsIn this video, we dive into the evolving pharmaceutical landscape with Dylan Jovine from Behind the Markets. We unpack the explosive growth expected in the weight loss drug industry, projected to hit a whopping $150-200 billion by 2030. There are major players strategically positioning themselves in this market, and we'll uncover the intense competition between giants like Novo Nordisk and Eli Lilly, fighting for dominance with their groundbreaking weight loss drugs. Plus, discover the potential impact on stock values and the healthcare industry as a whole. We'll also discuss the critical phase transitions in FDA drug approval, spotting opportunities, and why investing in biotech has Dylan so bullish on its future.Read Ozempic vs. Mounjaro:: Battle of the bulgeStocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioLLYEli Lilly and Company4.6381 of 5 stars4.64 / 5 stars$805.12-2.0%0.65%118.57NVONovo Nordisk A/S3.751 of 5 stars3.75 / 5 stars$126.72-0.9%1.05%43.70 Compare These Stocks Add These Stocks to My Watchlist Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeat625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored8 Retail Stocks to Own For the Long HaulAfter the 2020 e-commerce boom, everyone thought we had taken a 10-year leap in online shopping. Amazon was op...MarketBeat“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | Sponsored20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves a company that pays strong dividends. Who doesn't like receiving a check every quarter f...MarketBeatNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsored7 Dividend Dynamos with a Yield of More Than 7%Despite signs of a slowing economy, investors continue to climb the wall of worry. And let's face it, many of ...MarketBeat